Drug Shortage Report for SANDOZ SERTRALINE
Report ID | 88075 |
Drug Identification Number | 02245159 |
Brand name | SANDOZ SERTRALINE |
Common or Proper name | SERTRALINE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | SERTRALINE |
Strength(s) | 25MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100s |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-07-30 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2019-07-15 |
Shortage status | Avoided shortage |
Updated date | 2023-11-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-11-17 | French | Compare |
v4 | 2023-11-17 | English | Compare |
v3 | 2019-07-31 | English | Compare |
v2 | 2019-06-28 | French | Compare |
v1 | 2019-06-28 | English | Compare |
Showing 1 to 5 of 5